Cargando…

OCT4B1 Promoted EMT and Regulated the Self-Renewal of CSCs in CRC: Effects Associated with the Balance of miR-8064/PLK1

Cancer stem cells (CSCs) are the main cause of tumor generation, recurrence, metastasis, and therapy failure in various malignancies including colorectal cancer (CRC). Accumulating evidence suggests that tumor cells can acquire CSC characteristics through the epithelial-mesenchymal transition (EMT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jun-min, Hu, Shui-qing, Jiang, Hang, Chen, Yi-lin, Feng, Ji-hong, Chen, Zheng-quan, Wen, Kun-ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804455/ https://www.ncbi.nlm.nih.gov/pubmed/31650021 http://dx.doi.org/10.1016/j.omto.2019.08.004

Ejemplares similares

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Cancer stem cells (CSCs), cervical CSCs and targeted therapies
por: Huang, Ruixia, et al.
Publicado: (2016)

ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC
por: Lazarova, Darina, et al.
Publicado: (2017)

Pancreatic CSCs and microenvironment
por: Ilmer, Matthias, et al.
Publicado: (2015)

G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of Plk1
por: Zhang, Jie, et al.
Publicado: (2018)

ATLAS computing on CSCS HPC
por: Filipcic, Andrej, et al.
Publicado: (2015)

ATLAS computing on CSCS HPC
por: Hostettler, Michael Artur, et al.
Publicado: (2015)

CSCs: regenerating optimism for osteosarcoma treatment
por: Levin, Adam S.
Publicado: (2018)

Eradication of CSCs: the roadmap for curing cancer
por: Romano, Simona, et al.
Publicado: (2020)

Work on CMS Muon Detector (CSCs) during Long Shutdown 1
por: Lapka, Marzena
Publicado: (2015)

CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
por: Sulaiman, Andrew, et al.
Publicado: (2019)

Work on CMS Muon Detector (CSCs) during Long Shutdown 1 (LS1)
por: Hoch, Michael
Publicado: (2014)

Work on CMS Muon Detector (CSCs) during Long Shutdown 1 (LS1)
por: Heilman, Jesse
Publicado: (2014)

The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC)
por: Yang, Meiqi, et al.
Publicado: (2022)

Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC
por: Li, Jie-pin, et al.
Publicado: (2022)

Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS)
por: Leng, Xiaoling, et al.
Publicado: (2021)

Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling pathway in hepatocellular carcinoma
por: Sun, Lu, et al.
Publicado: (2017)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
por: Yi, You-Cai, et al.
Publicado: (2021)

NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation
por: Zhao, Tong, et al.
Publicado: (2021)

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
por: Lee, Kyung S, et al.
Publicado: (2008)

PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC)
por: Sun, Lei, et al.
Publicado: (2020)

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
por: Zhang, Yanlong, et al.
Publicado: (2023)

Correlation between cancer stem cells (CSCs) and tumor-infiltrating lymphocytes (TILs): do TILs interact with CSCs in non-small cell lung cancer?
por: Ling, Min, et al.
Publicado: (2020)

miR-23a suppresses pancreatic cancer cell progression by inhibiting PLK-1 expression
por: Chen, Bin, et al.
Publicado: (2018)

miR-23a suppresses pancreatic cancer cell progression by inhibiting PLK-1 expression
por: Chen, Bin, et al.
Publicado: (2022)

Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p
por: Li, Hongdan, et al.
Publicado: (2018)

Plk1 in Asthma: Ready for Primetime?
por: Tam, John Kit Chung, et al.
Publicado: (2021)

Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
por: Chen, Jen-Shi, et al.
Publicado: (2018)

Enabling ATLAS big data processing on Piz Daint at CSCS
por: Sciacca, Francesco Giovanni, et al.
Publicado: (2019)

Enabling ATLAS big data processing on Piz Daint at CSCS
por: Sciacca, Francesco Giovanni, et al.
Publicado: (2020)

Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

Resistance to drugs and cell death in cancer stem cells (CSCs)
por: Safa, Ahmad R
Publicado: (2020)

Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
por: Li, Dai, et al.
Publicado: (2023)

The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
por: Chen, Engeng, et al.
Publicado: (2016)

miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
por: Chen, Miao, et al.
Publicado: (2017)

BGN and COL11A1 Regulatory Network Analysis in Colorectal Cancer (CRC) Reveals That BGN Influences CRC Cell Biological Functions and Interacts with miR-6828-5p
por: Chen, Danqi, et al.
Publicado: (2020)

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133(+) A549 cell fraction
por: Tirino, V, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o0ia003aq8kv7oa2g1c3e8trfn